3 Australian Penny Stocks With Stronger Balance Sheets Than Most Peers
Penny stocks often attract attention for their low share prices, but the wide range of quality can make selection difficult, especially while inflation paths, interest rate expectations and geopolitical risks keep moving. The Financially Fit Penny Stocks screener aims to narrow that field by focusing on smaller companies with healthier balance sheets and a lower risk profile than many early stage peers. That can help you stay exposed to potential growth while keeping an eye on financial resilience. In this article you will see three of the most interesting stocks from this screener and why they stand out now.
Ora Banda Mining (ASX:OBM)
Overview: Ora Banda Mining is an Australian resources company focused on exploring, developing and operating gold projects, with additional exposure to nickel, copper and lithium, anchored by its 100% owned Davyhurst Gold Project near Kalgoorlie.
Operations: Ora Banda Mining generates all of its A$554.1 million in revenue from gold production and exploration in Australia.
Market Cap: A$2.23b
Ora Banda Mining catches the eye because it combines strong recent earnings growth with a relatively low P/E and a share price that currently sits well below one estimate of its future cash flow value. The company reports net profit margins of 41.8% and is working to expand resources at Davyhurst, with sizeable upgrades to mineral resources and ore reserves and further drilling planned through FY2027. At the same time, investors need to weigh the reliance on higher risk external funding and a significant non cash earnings component, which can complicate valuation work. For investors seeking exposure to a growing Australian gold producer with an active exploration pipeline, Ora Banda Mining may warrant closer consideration.
Ora Banda Mining’s mix of high margins, active exploration and a low P/E suggests that the market might be missing something. Get the full picture with the 4 key rewards and 1 important major warning sign
DroneShield (ASX:DRO)
Overview: DroneShield is an Australian defence technology company that builds hardware and software systems to detect and neutralise hostile drones for military, government, critical infrastructure and major event security customers around the world.
Operations: DroneShield generates all of its A$216.8 million in revenue from aerospace and defence activities, with sales spread across the USA and other international markets.
Market Cap: A$1.92b
DroneShield may be relevant to investors considering defence exposure because it operates in the counter-drone segment, with recent profitability, reported earnings quality and new defence contracts including A$23.2 million in European deals and work on FIFA World Cup 2026 security. The company is aiming for repeat institutional procurement, yet still faces risks related to revenue volatility, reliance on higher risk external funding and an ASIC inquiry into past disclosures. Board refresh and the appointment of Rear Admiral Lee Goddard add defence sector experience. For investors who can tolerate these uncertainties, DroneShield is a stock that some may choose to monitor closely.
DroneShield sits at the crossroads of fast-moving defence demand and emerging drone risks, yet the full story is not obvious from headlines alone. Get the analyst forecasts for DroneShield and see what the recent contracts might really be signalling.
Sigma Healthcare (ASX:SIG)
Overview: Sigma Healthcare is an Australian pharmacy wholesaler and retail franchisor that supplies medicines and health products to community pharmacies, supports franchise networks like Chemist Warehouse, Amcal and Discount Drug Stores, and runs logistics and health services operations across its store network and online channels.
Operations: Sigma Healthcare generates A$9.55b in revenue from healthcare products and services, with A$9.16b from Australia and about A$389.79m from international markets.
Market Cap: A$34.16b
Sigma Healthcare appears on the Financially Fit Penny Stocks screener because it combines scale in Australian pharmacy distribution with long term earnings growth and revenue forecasts that are ahead of the broader market. At the same time, the stock trades on a high P/E multiple and profit margins have eased from 11.5% to 6.3%, which means investors are paying a higher price while returns on equity remain moderate. In addition, the balance sheet leans on higher risk borrowings and there is a relatively new board and management team, so governance is an important area to monitor. For investors who want exposure to healthcare spending and are comfortable with these trade offs, Sigma Healthcare may warrant further research.
Sigma Healthcare’s growth story and premium P/E may look aligned at first glance, yet the real tension sits in those easing margins and gearing. Get the analyst forecasts for Sigma Healthcare and see what could shift that balance next.
The three stocks in this article are only a small sample, with the full screener highlighting 405 more companies that passed the same Financially Fit Penny Stocks filters and each carrying its own potential narrative inside the Financially Fit Penny Stocks screener. Use Simply Wall St to identify, analyze and filter for the exact catalysts and financial traits that matter to you so you can focus on the penny stocks that best match your highest conviction ideas.
Take Control of Your Investment Journey
If Ora Banda Mining or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.
Seeking Fresh Alternatives Before They Fly
Some stocks are building momentum quietly while attention stays elsewhere. Spot potential breakouts that are under the radar for now and consider them before the broader market reacts.
- Scan for growth stories with solid footing and focus on companies from the 12 high quality undiscovered gems before others turn to them later.
- Explore potential infrastructure-related opportunities by reviewing companies in the 36 power grid technology and infrastructure stocks while market attention is directed elsewhere.
- Follow long term income themes by reviewing the curated 3 dividend fortresses that could help support portfolio cash flow when it is a priority.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com